Risankizumab (Psoriatic arthritis): Injection 150 mg in 1 mL pre-filled syringe, Injection 150 mg in 1 mL pre-filled pen; Skyrizi® Page last updated: 1 July 2022 Public Summary Document (PSD) March 2022 PBAC Meeting - (PDF 747KB) Public Summary Document (PSD) March 2022 PBAC Meeting - (Word 143KB)